| Typicality: | 0.372 |
| Saliency: | 0.210 |
| as a customer | 4 | manner |
| during pregnancy | 3 | temporal |
| in developing nations | 2 | location |
| vaccine → be administered to → woman | 11 |
| vaccine → be tested on → woman | 3 |
| negative | neutral | positive |
| 0.353 | 0.506 | 0.142 |
| Raw frequency | 14 |
| Normalized frequency | 0.210 |
| Modifier score | 0.600 |
| Perplexity | 73.027 |